Royalty Transparency Act

Increased Transparency for Public Health Advice: By requiring members of specific advisory committees—such as the Advisory Committee on Immunization Practices and the National Vaccine Advisory Committee—to disclose royalties, the bill provides clarity on potential financial interests behind public health recommendations. (Section 2(a))

Enhanced Oversight of Financial Waivers: The bill requires that any exemptions or waivers granted regarding financial disclosures be immediately reported to specific Senate and House Committees, including a detailed justification. (Section 2(b))

Public Access to Financial Information: The Act mandates that agencies publish reports on their websites listing the names of covered individuals and the original source and amount of royalties received, allowing for greater public scrutiny of government employees' financial interests. (Section 2(c) and Section 2(e))

Prevention of Organizational Conflicts: The bill directs the updating of regulations to ensure that conflict of interest reviews for prospective contractors or grantees include reviews of royalties paid in the preceding calendar year, which helps mitigate potential organizational conflicts of interest. (Section 3(a))

Increased Reporting Burdens for Employees: The bill introduces new requirements for various executive branch employees and advisory committee members to disclose the original source and value of royalties received by themselves, their spouses, or their dependent children. (Section 2(c) and Section 2(e))

Mandatory Disclosure of Private Financial Data: The requirement to report the specific amount and source of royalties received by a spouse or dependent child could be seen as an intrusion into the financial privacy of an employee's family. (Section 2(c))